Lotus Eye Hospital and Institute Ltd

Stage 4 · Declining · week 4

As of 16 Oct 2026, Lotus Eye Hospital and Institute is in Stage 4 — declining, a downtrend, in week 4 (since 18 Sep 2026). It closed at ₹114, 19.1% below its 52-week high and below its 200-day average, which is falling. In Health Care, 40.6% of stocks are in Stage 2.

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. More about the company

₹114.4
+4.53% today
₹238 Cr · Micro cap
Market Neutral — FadingHealth Care 40.6% in Stage 2-7.4 pts / 20dHospitals & Diagnostic Centres 19.4%-19.4 pts

Pro read

Pro

Our read

Declining — below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is LOTUSEYE early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-19.1%
₹98.2 lo₹141.4 hi
19.1% below 52W high — ongoing decline
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 4
1w13w26w
Week 4 — early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
-1.2%
200 DMA: ₹115.7 · sloping down
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
0.54x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
↗
MA20 gently rising · +0.6% vs MA50 -2.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-0.5%
3M
-6.3%
6M
+4.7%
YTD
-8.3%
1Y
-4.9%
Sector
Health Care
↓ Peaking
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 67 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
19.4%
20d Δ
-19.4pp
1M return
-10.4%
3M return
-12.2%
Industry Stage-2 % · last 20 days
Industry has 5 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Stage Cycle Timeline2023-07-20 → 2026-10-16
S4 23w
S3 15w
S2 15w
2023-07-202026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 11w → S3 6w → S2 10w → S3 2w → S4 23w → S1 8w → S2 8w → S3 15w → S4 10w → S1 4w → S2 9w → S3 2w → S2 15w → S3 5w → S2 2w → S3 3w → S2 5w → S3 8w → S4 4w → S1 2w → S2 9w → S3 3w → S4 4w current
Total tracked: 167 weeks across 23 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-06-22
6 appearances in last 60 days. First seen: 2024-09-13.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding — staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-16S4
Wk 4 · Vol 0.54x
2026-10-15S4
Wk 4 · Vol 4.50x
2026-10-14S4
Wk 4 · Vol 1.26x
2026-10-13S4
Wk 4 · Vol 7.78x
2026-10-12S4
Wk 4 · Vol 4.41x
2026-10-09S4
Wk 3 · Vol 0.57x
2026-10-08S4
Wk 3 · Vol 0.22x
2026-10-07S4
Wk 3 · Vol 0.28x
2026-10-06S4
Wk 3 · Vol 0.99x
2026-10-05S4
Wk 3 · Vol 0.27x
2026-10-01S4
Wk 2 · Vol 0.44x
2026-09-30S4
Wk 2 · Vol 0.33x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹113.6
200 DMA
₹115.7
52W High
₹141.4
52W Low
₹98.2
5D Low
₹107.1
Resistance levels (recent highs)
20d High
₹115.9
60d High
₹119.8
120d High
₹140
250d High
₹141.4
Next resistance
+1.3%
to 20d High
Ask the Market AI about LOTUSEYEAsk →
P/E (TTM)
338.4
Forward —
About this companyHealth Care· Hospitals & Diagnostic Centres

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.